Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, discusses data from an analysis of prediabetic/obese patients with hormone receptor (HR)-postive, HER2-negative locally advanced/metastatic breast cancer...
Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, reviews findings from a single-center retrospective analysis on how body composition measures—such as total fat, visceral fat, subcutaneous fat, skeletal muscle area, skeletal muscle density and muscular adiposity—affected progression-free survival and adverse events rates in patients receiving CDK4/6 inhibitors for estrogen receptor–positive (ER+)/HER2-negative metastatic breast cancer...
Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, reviews new data from the INAVO120 study presented at the 2025 ASCO Annual Meeting—the final overall survival analysis and updated results on safety, efficacy, and toxicity...
